BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/12/2014 8:41:00 PM | Browse: 1279 | Download: 1485
 |
Received |
|
2013-06-06 08:52 |
 |
Peer-Review Started |
|
2013-06-07 19:10 |
 |
First Decision by Editorial Office Director |
|
|
 |
Return for Revision |
|
2013-07-22 18:16 |
 |
Revised |
|
2013-07-31 23:47 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2013-08-19 12:28 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2013-08-20 00:25 |
 |
Articles in Press |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2013-10-13 20:47 |
 |
Publish the Manuscript Online |
|
2013-11-13 08:37 |
| Category |
Pathology |
| Manuscript Type |
Case Report |
| Article Title |
Angiotensin-Ⅱ inhibitor (olmesartan)-induced collagenous sprue with resolution following discontinuation of drug
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Jennifer A Nielsen, Anita Steephen and Matthew Lewin |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Matthew Lewin, MD, Division of Gastrointestinal Pathology, ProPath Laboratory, 1355 River Bend Dr., Dallas, TX 75247, United States. matthew.lewin@propath.com |
| Key Words |
Collagenous sprue; Celiac disease; Olmesartan; Patient-drug interaction; Duodenum |
| Core Tip |
Collagenous sprue (CS) is a pattern of small-bowel injury characterized histologically by marked villous blunting, intraepithelial lymphocytes, and thickened sub-epithelial collagen table. Clinically, patients present with diarrhea, abdominal pain, malabsorption, and weight loss, which raises suspicion of celiac disease. Clinicians should be aware of the possibility of drug-induced CS and potential reversibility after discontinuation of medication. |
| Publish Date |
2013-11-13 08:37 |
| Citation |
Nielsen JA, Steephen A, Lewin M. Angiotensin-Ⅱ inhibitor (olmesartan)-induced collagenous sprue with resolution following discontinuation of drug. World J Gastroenterol 2013; 19(40): 6928-6930 |
| URL |
http://www.wjgnet.com/1007-9327/full/v19/i40/6928.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v19.i40.6928 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.